AN EFFICACIOUS HEALTHCARE SUPPLEMENT FORMULATION FOR THE PREVENTION, CONTROL AND CLINICAL IMPROVEMENT OF MULTIPLE DISEASED CONDITIONS LIKE, OBESITY, TYPE 2 DIABETIC MELLITUS, HYPERLIPIDEMIA AND ASSOCIATED CIRCULATORY SYSTEM AILMENTS IN HUMAN
The invention deals with a process of making an efficacious Nutraceutical dietary food supplement Formulation for the prevention, control and clinical improvement of multiple diseased conditions like, Obesity, Type 2 diabetic mellitus, hyperlipidemia and associated circulatory system ailments in man. The formulation may be comprising of alpha amylase inhibitors in the form of protein derived from wheat grain or from the sources of white kidney bean extract with a standardized phaseolamin content which has been formulated specially with other active ingredients like calcium form of EDTA and a common salt of NaC1 and the final adjusted pH of the product would be in the range of 4-6 in a well known and accepted form of Tris-buffer as the formulation base. The formulation may also contain a suitable form of probiotics in order to minimize or completely eliminate the possible chances of creating gas and gastric related disturbances associated with the use of plant derived alpha amylase inhibitors as a food, dietary supplement for human consumption. Thereby the formulation found to be superior in its composition not available so far for human use, addresses the many problems of presently available alpha amylase inhibitor based formulations like, active ingredient inactivation, decreased efficacy in vivo and inefficient activity against salivary amylases. The present formulation also provides solutions to the additional problems associated with any obese person like of cholesterol and related circulatory system complications related to obesity. Overall a single product would therefore be helpful to the humankind maintaining a healthy body by preventing from multiple complications of obesity.
